GROUP ONE TRADING, L.P. - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 151 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$5,378
-67.8%
4,980
-55.3%
0.00%
Q4 2022$16,700
-72.2%
11,133
-78.2%
0.00%
Q3 2022$60,000
+20.0%
50,968
+14.3%
0.00%
Q2 2022$50,000
-69.3%
44,584
-18.2%
0.00%
Q1 2022$163,000
-47.2%
54,534
-53.3%
0.00%
Q4 2021$309,000
-31.0%
116,724
-5.4%
0.00%
Q3 2021$448,000
+361.9%
123,392
+451.7%
0.00%
Q2 2021$97,000
-35.3%
22,366
-47.8%
0.00%
Q4 2020$150,000
-30.6%
42,842
-48.9%
0.00%
-100.0%
Q1 2019$216,000
+4220.0%
83,898
+3447.5%
0.00%
Q4 2018$5,000
-84.4%
2,365
-71.6%
0.00%
Q4 2017$32,000
+166.7%
8,338
+76.0%
0.00%
Q3 2017$12,000
-20.0%
4,738
-16.0%
0.00%
Q2 2017$15,000
-87.8%
5,638
-89.8%
0.00%
-100.0%
Q2 2016$123,000
+623.5%
55,220
+595.8%
0.00%
Q1 2016$17,000
-82.8%
7,936
-74.2%
0.00%
-100.0%
Q2 2015$99,00030,710
+66660.9%
0.00%
Q4 2014$0
-100.0%
46
-99.7%
0.00%
-100.0%
Q4 2013$47,000
-27.7%
16,576
-9.2%
0.00%0.0%
Q3 2013$65,00018,2580.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
CM Management, LLC 1,500,000$1,620,0001.72%
Soleus Capital Management, L.P. 14,803,015$15,987,2561.48%
ARMISTICE CAPITAL, LLC 17,136,000$18,506,8800.28%
SPHERA FUNDS MANAGEMENT LTD. 1,228,126$1,326,3760.24%
GSA CAPITAL PARTNERS LLP 971,441$1,0490.09%
NJ State Employees Deferred Compensation Plan 200,000$216,0000.03%
Providence Wealth Advisors, LLC 27,500$29,0130.03%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 1,151,765$1,243,9060.03%
XTX Topco Ltd 164,238$177,3770.03%
JACOBS LEVY EQUITY MANAGEMENT, INC 3,369,076$3,638,6020.02%
View complete list of RIGEL PHARMACEUTICALS INC shareholders